Inventor · disambiguated record
Sheila Dewitt
Also filed as: DEWITT SHEILA · DEWITT SHEILA H · DEWITT SHEILA H H · DEWITT SHEILA HELEN
36 granted patents·27 pending applications·1,620 citations·filing 1993–2025
98Inventor score
Top patents by PatentIndex Score
63 records- 0198US9732031B2Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropionDEUTERX LLC·Filed 2014·Granted Aug 15, 2017·121 cites·9 claims
- 0298US5324483AApparatus for multiple simultaneous synthesisWARNER LAMBERT CO·Filed 1993·Granted Jun 28, 1994·400 cites·54 claims
- 0396US11535603B1Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disorders using sameDEUTERX LLC·Filed 2020·Granted Dec 27, 2022·4 cites·15 claims
- 0495US9833445B25-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2016·Granted Dec 5, 2017·12 cites·42 claims
- 0595US9416117B25-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2015·Granted Aug 16, 2016·12 cites·35 claims
- 0695US9290475B23-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2014·Granted Mar 22, 2016·10 cites·31 claims
- 0795US8969581B25-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2014·Granted Mar 3, 2015·19 cites·31 claims
- 0895US6485690B1Multiple fluid sample processor and systemORCHID BIOSCIENCES INC·Filed 1999·Granted Nov 26, 2002·451 cites·53 claims
- 0994US5714127ASystem for multiple simultaneous synthesisWARNER LAMBERT CO·Filed 1995·Granted Feb 3, 1998·138 cites·31 claims
- 1093US5766556AApparatus and method for multiple simultaneous synthesisWARNER LAMBERT CO·Filed 1996·Granted Jun 16, 1998·88 cites·12 claims
- 1192US9540340B23-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2014·Granted Jan 10, 2017·12 cites·4 claims
- 1292US9090585B22,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compoundsDEWITT SHEILA·Filed 2012·Granted Jul 28, 2015·24 cites·23 claims
- 1392US5593642AApparatus for multiple simultaneous synthesisWARNER LAMBERT CO·Filed 1995·Granted Jan 14, 1997·81 cites·11 claims
- 1490US2025302838A13-(substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2024·Application pending·0 cites
- 1588US11123336B25-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the samePOXEL SA·Filed 2019·Granted Sep 21, 2021·2 cites·21 claims
- 1688US5612002AApparatus and method for multiple simultaneous synthesisWARNER LAMBERT CO·Filed 1995·Granted Mar 18, 1997·59 cites·36 claims
- 1787US10202316B23-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2016·Granted Feb 12, 2019·4 cites·18 claims
- 1884US6183645B1Methods and apparatus for liquid phase separationFiled 1998·Granted Feb 6, 2001·54 cites·20 claims
- 1983US10265305B25-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the samePOXEL SA·Filed 2017·Granted Apr 23, 2019·2 cites·9 claims
- 2083US10188639B2Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazoneDEUTERX LLC·Filed 2015·Granted Jan 29, 2019·3 cites·20 claims
- 2183US2023277539A13-(substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2022·Application pending·0 cites
- 2282US2024417368A1Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropionDEUTERX LLC·Filed 2024·Application pending·0 cites
- 2380US2025320192A1Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disorders using sameDEUTERX LLC·Filed 2024·Application pending·0 cites
- 2478US11918569B25-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the samePOXEL SA·Filed 2021·Granted Mar 5, 2024·0 cites·28 claims
- 2578US9913845B23-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2016·Granted Mar 13, 2018·1 cites·20 claims
- 2678US2022213023A1Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropionDEUTERX LLC·Filed 2022·Application pending·0 cites
- 2776US11820720B23-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deuteropiperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2021·Granted Nov 21, 2023·0 cites·10 claims
- 2876US2023242504A1Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disorders using sameDEUTERX LLC·Filed 2022·Application pending·0 cites
- 2976US2025268879A1Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazonePOXEL SA·Filed 2025·Application pending·0 cites
- 3074US11491156B23-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2019·Granted Nov 8, 2022·0 cites·14 claims
- 3174US2023218595A1Combination therapy using enantiopure, oxy-substituted, deuterium-enriched 5-(benzyl)-5-deutero-thiazolidine-2,4-diones for treatment of medical disordersDEUTERX LLC·Filed 2022·Application pending·0 cites
- 3273US11141411B2Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazonePOXEL SA·Filed 2018·Granted Oct 12, 2021·0 cites·18 claims
- 3373US2021387940A1Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropionDEUTERX LLC·Filed 2021·Application pending·0 cites
- 3473US2022193055A1Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazonePOXEL SA·Filed 2021·Application pending·0 cites
- 3571US10555946B23-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2017·Granted Feb 11, 2020·0 cites·22 claims
- 3669US11040925B23-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameDEUTERX LLC·Filed 2018·Granted Jun 22, 2021·0 cites·17 claims
- 3768US5702672AApparatus and method for multiple simultaneous synthesisWARNER LAMBERT CO·Filed 1995·Granted Dec 30, 1997·30 cites·4 claims
- 3867US5582801AApparatus for multiple simultaneous synthesisWARNER LAMBERT CO·Filed 1995·Granted Dec 10, 1996·19 cites·11 claims
- 3967US2022362220A15-deutero-thiazolidine-2,4-dione compounds and methods of treating medical disorders using samePOXEL SA·Filed 2020·Application pending·0 cites
- 4067US2025382240A13-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the sameSALARIUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4166US2020253937A15-deutero-thiazolidine-2,4-dione compounds and methods of treating medical disorders using samePOXEL SA·Filed 2019·Application pending·0 cites
- 4264US11319313B2Crystalline forms of deuterium-enriched pioglitazonePOXEL SA·Filed 2021·Granted May 3, 2022·0 cites·14 claims
- 4362US2023074827A1Crystalline forms of deuterium-enriched pioglitazonePOXEL SA·Filed 2022·Application pending·0 cites
- 4461US2018327379A12',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compoundsDEUTERX LLC·Filed 2018·Application pending·0 cites
- 4561US2020239457A15-deutero-thiazolidinyldione compounds and methods of treating medical disorders using samePOXEL SA·Filed 2019·Application pending·0 cites
- 4660US2017369420A1Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropionDEUTERX LLC·Filed 2017·Application pending·0 cites
- 4760US2018125827A15-deutero-thiazolidine-2,4-dione compounds and methods of treating medical disorders using sameDEUTERX LLC·Filed 2017·Application pending·0 cites
- 4860US2020390753A1Combination therapy using enantiopure, oxy-substituted, deuterium-enriched 5-(benzyl)-5-deutero-thiazolidine-2,4-diones for treatment of medical disordersPOXEL SA·Filed 2019·Application pending·0 cites
- 4959US2018118712A12',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compoundsDEUTERX LLC·Filed 2017·Application pending·0 cites
- 5057US5567391AApparatus for multiple simultaneous synthesisWARNER LAMBERT CO·Filed 1995·Granted Oct 22, 1996·16 cites·11 claims
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sheila Dewitt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →